Tag: property portfolio

TORONTO, Aug. 06, 2025 (GLOBE NEWSWIRE) -- European Residential Real Estate Investment Trust ("ERES" or the "REIT") (TSX: ERE.UN) announced today its results for the three and six months ended June 30, 2025.

SALE OF INVESTMENT PROPERTIES FOR GROSS PROCEEDS OF $15 MILLION
SAME PROPERTY NOI INCREASE
NAV GROWTH AND DECLINING AFFO PAYOUT RATIO

- Increased 2025 AFFO Guidance $0.04 to $1.24 - $1.26 per diluted share -
- Acquired 68 USPS Properties for $35.9 million at a Weighted Average Capitalization Rate of 7.8% -
- Raised $12.8 million from ATM Program During the Second Quarter and Subsequent to Quarter End to Fund Acquisitions -

GAAP Net Income of $0.04 Per Diluted Share for the Second Quarter

WARREN, N.J., Aug. 01, 2025 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN), today released a letter to stockholders.

HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 275+ patents issued and pending with a focus on the development of therapeutics and potential cures for chronic diseases using fibroblasts and fibroblast-derived materials, today announced second quarter 2025 financial results and provided a corporate update.

Net Income per Diluted Share of $10.02 for the Quarter, inclusive of Income from Discontinued Operations

– New patent enhances market position in Europe

JACKSONVILLE, Fla., July 29, 2025 (GLOBE NEWSWIRE) -- Regency Centers Corporation (“Regency Centers,” “Regency” or the “Company”) (Nasdaq: REG) today reported financial and operating results for the quarterly period ended June 30, 2025, and provided updated 2025 earnings guidance. For the three months ended June 30, 2025 and 2024, Net Income Attributable to Common Shareholders was $0.56 per diluted share, and $0.54 per diluted share, respectively.

– Signed 190,000 square feet of comparable leases at 22% growth in cash rent spread –
– Reaffirmed 2025 Outlook –

Charles D. Young Appointed Chief Executive Officer and Appointed to the Board of Directors, Effective October 1, 2025;  Gary A. Shiffman to Transition to Non-Executive Chairman of the Board